Rare Catechol-O-methyltransferase Missense Variants Are Structurally Unstable Proteasome Targets

Area of Science:

• Biochemistry
• Neurobiology
• Pharmacology

Background:

• Catechol-O-methyltransferase (COMT) is crucial for metabolizing catecholamines like dopamine and epinephrine.
• COMT also affects the metabolism of drugs such as L-DOPA, impacting their availability.
• Genetic variations in COMT can alter enzyme activity and influence neurotransmitter and drug levels.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the reduced activity of specific COMT missense variants.
• To determine if structural instability and protein degradation contribute to the loss of function in these variants.
• To explore the potential rescue of COMT variant function by COMT inhibitors.

Main Methods:

• Ubiquitination assays to detect protein modification.
• Proteasomal degradation studies to assess enzyme turnover.
• Analysis of both soluble (S-COMT) and membrane-bound (MB-COMT) isoforms.
• In silico structural stability predictions.
• Enzyme activity assays in the presence and absence of COMT inhibitors (entacapone, tolcapone).

Main Results:

• Two rare COMT missense variants were found to be ubiquitylated and degraded by the proteasome due to misfolding and structural destabilization.
• This degradation led to significantly reduced intracellular enzyme levels.
• The L135P variant's degradation was partially rescued by the COMT inhibitors entacapone and tolcapone.
• Degradation occurred for both S-COMT and MB-COMT isoforms.
• In silico analysis identified critical stability regions and conserved residues, suggesting other variants may also be destabilized.

Conclusions:

• Structural instability and subsequent proteasomal degradation are key mechanisms for loss-of-function in certain rare COMT variants.
• COMT inhibitors may offer a therapeutic strategy to stabilize and rescue the function of specific destabilized COMT variants.
• Understanding these degradation pathways is vital for predicting drug efficacy and neurobiological outcomes influenced by COMT activity.